Simplify Logo

Full-Time

Associate Director

Pharmaceutical Sciences

Posted on 6/18/2024

Tarsus Pharamceuticals

Tarsus Pharamceuticals

201-500 employees

Biopharmaceuticals for eye and infectious diseases

Biotechnology
Healthcare

Compensation Overview

$138k - $194.3kAnnually

+ Bonus + Stock Equity

Senior, Expert

Irvine, CA, USA

Hybrid work environment.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Management
Requirements
  • B.S. /M.S./Ph.D. in one of the relevant Engineering, Pharmaceutical Sciences, or other related Science fields. Formal project management and/or Lean Six Sigma certifications preferred.
  • A minimum of twelve (12) years of engineering work experience, preferably in pharmaceutical development and manufacturing environment, and hands-on or technical training in the field of process engineering depending on level of education.
  • At least 5 years of people management experience and within a growing virtual company environment preferred.
  • Strong understanding of development, scale-up, validation and technology transfer; cGMP, FDA, EU, ICH guidelines; as well as CMC content of regulatory submission.
  • Demonstrate scientific knowledge relevant to formulation development and process development of small molecule/ biologics and/or peptides to be delivered through ophthalmic and/or injectable routes. Knowledge of analytical skills related to identified formulation.
  • Drug product manufacturing process design and scale-up including equipment, testing, assembly operations and support systems.
  • Current Good Manufacturing Practices (cGMP), Food and Drug Administration (FDA), and other regulatory and safety compliance requirements and guidelines.
  • Pharmaceutical industry practices with aseptic manufacturing and combination product experience preferred.
Responsibilities
  • Leads formulation and process development of Tarsus products to be delivered through ocular, oral and dermal routes.
  • Leads an in-house laboratory and formulation development team responsible for formulation development from lead candidate identification and optimization to clinical development.
  • Providing hands-on management for in-house formulation development including: designing, planning and executing experiments; interpreting analytical and process data; and coordinating activities with the analytical development department.
  • Leads early and mid-phase activities for new product technology transfer to CMO sites providing product and process design input, defining specifications for equipment, selecting equipment suppliers, and locking down formulation and clinical manufacturing process. Coordinate and facilitate transfer of product manufacture to additional CMO site(s).
  • Responsible for leading and overseeing all aspects of the manufacture of early and mid-phase products at CMOs and ensuring adherence to project timelines to E/L studies, support animal PK, toxicology and/or clinical supply in line with business objectives.
  • Establish and manage relationships with CMOs. Reviews and provides oversight of all documentation related to the production of Tarsus’s products including but not limited to scale-up protocols/reports batch records, deviations, SOP’s, etc. Contributes to setting up specifications for drug products. In conjunction with the CMO and other groups related deviations and leads or conduct root cause analysis and implement proposed corrective actions at CMO.
  • Work collaboratively with the supply chain manager to facilitate manufacturing, packaging, and distribution of early and mid-phase clinical trial material activities.
  • Provide early and mid-phase product technical support including technical interface with regulatory, quality, project manager, contract manufacturers, vendors, and suppliers.
  • Support regulatory CMC activities including writing and/or reviewing drug product regulatory submissions and ensures that documents are prepared in accordance with regulatory guidelines.
  • Collaborate with the analytical team to conduct formulation experimental assessment.
  • Support due diligence assessments of potential intellectual property and business development opportunities.
  • R&D project budget planning and budget management.
  • May perform other related duties as required and/or assigned.
Tarsus Pharamceuticals

Tarsus Pharamceuticals

View

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company also has a pipeline of potential treatments for other conditions, including Lyme Disease Prevention and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong commitment to ethical practices and compliance. The goal of Tarsus Pharmaceuticals is to provide effective medical treatments that improve patient outcomes in areas where there are currently few options.

Company Stage

IPO

Total Funding

$610.6M

Headquarters

Irvine, California

Founded

2017

Growth & Insights
Headcount

6 month growth

17%

1 year growth

25%

2 year growth

221%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $200 million in non-dilutive financing from Pharmakon Advisors strengthens Tarsus's financial position, enabling further R&D and market expansion.
  • Positive Phase 2a trial results for TP-05 for Lyme Disease prevention indicate promising future product offerings and potential market growth.
  • Recognition through awards like the Zero to Launch Award highlights Tarsus's innovative approach and successful commercialization strategies.

What critics are saying

  • The biopharmaceutical market is highly competitive and capital-intensive, requiring continuous innovation and substantial investment to maintain a competitive edge.
  • Dependence on the success of a limited number of products, such as XDEMVY, makes the company vulnerable to market fluctuations and regulatory changes.

What makes Tarsus Pharamceuticals unique

  • Tarsus Pharmaceuticals focuses on high unmet medical needs in eye care and infectious diseases, setting it apart from competitors with broader but less specialized portfolios.
  • Their flagship product, XDEMVY, is FDA-approved for treating Demodex Blepharitis, a niche condition with limited treatment options, giving them a unique market position.
  • The company's commitment to ethical operations and robust compliance programs ensures trust and reliability among healthcare providers and patients.
INACTIVE